Free Trial
→ I'm handing you this one free (From Behind the Markets) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
$213.63
+1.7%		$208.46
$154.98
▼
$222.29
$11.04B0.721.86 million shs2.16 million shs
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$3.52
+0.6%		$3.77
$2.77
▼
$5.24
$1.88B1.1525.50 million shs15.55 million shs
Tempus AI, Inc. stock logo
TEM
Tempus AI
$76.05
+8.0%		$71.32
$40.77
▼
$89.09
$13.72B3.616.39 million shs6.28 million shs
10 Stocks Powering The Next AI Boom Cover
10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
0.00%-1.83%+6.56%+8.05%+34.94%
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
0.00%-12.66%-10.89%+9.32%-29.03%
Tempus AI, Inc. stock logo
TEM
Tempus AI
0.00%+5.30%+9.77%+46.11%-7.55%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
$213.63
+1.7%		$208.46
$154.98
▼
$222.29
$11.04B0.721.86 million shs2.16 million shs
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$3.52
+0.6%		$3.77
$2.77
▼
$5.24
$1.88B1.1525.50 million shs15.55 million shs
Tempus AI, Inc. stock logo
TEM
Tempus AI
$76.05
+8.0%		$71.32
$40.77
▼
$89.09
$13.72B3.616.39 million shs6.28 million shs
10 Stocks Powering The Next AI Boom Cover
10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
0.00%-1.83%+6.56%+8.05%+34.94%
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
0.00%-12.66%-10.89%+9.32%-29.03%
Tempus AI, Inc. stock logo
TEM
Tempus AI
0.00%+5.30%+9.77%+46.11%-7.55%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
2.66
Moderate Buy$213.63N/A
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
2.20
Hold$8.18132.39% Upside
Tempus AI, Inc. stock logo
TEM
Tempus AI
2.45
Hold$79.374.36% Upside

Current Analyst Ratings Breakdown

Latest TEM, RXRX, and IBB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/3/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetBuy$80.00 ➝ $100.00
11/3/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Jefferies Financial Group Inc. logo
Jefferies Financial Group
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeUnderperform ➝ Hold$35.00 ➝ $70.00
11/3/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Cantor Fitzgerald logo
Cantor Fitzgerald
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetOverweight$80.00 ➝ $92.00
11/3/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetOutperform$85.00 ➝ $92.00
11/3/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetBuy$68.00 ➝ $85.00
11/2/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetBuy$75.00 ➝ $89.00
10/26/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetBuy$66.00 ➝ $68.00
10/26/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingBuy$80.00
10/23/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingBuy$75.00
10/19/2026
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingBuy$8.00
10/16/2026
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access to unlock brokerage rankings
Set Price Target$5.90
(Data available from 11/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
N/AN/AN/AN/AN/AN/A
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$74.68M25.23N/AN/A$1.69 per share2.08
Tempus AI, Inc. stock logo
TEM
Tempus AI
$1.27B10.79N/AN/A$2.77 per share27.45
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
-$644.76M-$0.90N/AN/AN/A-697.15%-47.85%-36.26%N/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
-$245.03M-$1.06N/AN/AN/A-12.54%-47.00%-9.44%N/A

Latest TEM, RXRX, and IBB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/2/2026Q3 2026 & Study Update
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
-$0.2190-$0.22-$0.0010-$0.22$14.81 million$18.55 million
11/2/2026Q3 2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
-$0.0937$0.07+$0.1637-$0.08$409.39 million$411.54 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
$0.340.16%N/AN/AN/A
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
N/AN/AN/AN/AN/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
N/AN/AN/AN/AN/A

Latest TEM, RXRX, and IBB Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/14/2026
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
quarterly$0.01120.02%9/15/20269/15/20269/18/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
N/AN/AN/A
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
N/A
5.01
5.03
Tempus AI, Inc. stock logo
TEM
Tempus AI
2.70
2.61
3.16

Institutional Ownership

CompanyInstitutional Ownership
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
62.45%
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
89.06%
Tempus AI, Inc. stock logo
TEM
Tempus AI
24.22%

Insider Ownership

CompanyInsider Ownership
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
N/A
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
6.65%
Tempus AI, Inc. stock logo
TEM
Tempus AI
24.26%
CompanyEmployeesShares OutstandingFree FloatOptionable
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
N/A51.70 millionN/AOptionable
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
600535.34 million499.74 millionOptionable
Tempus AI, Inc. stock logo
TEM
Tempus AI
3,800180.43 million136.66 millionOptionable

Recent News About These Companies

Tempus AI: Q3 Strengthens The Platform Thesis, But Cash Returns Still Need To Catch Up
November 7 at 10:00 PM  |  seekingalpha.comhttps://seekingalpha.com/article/4964797-tempus-ai-stock-q3-strengthens-platform-thesis-cash-returns-need-to-catch-up
Tempus AI, Inc. Class A (TEM) Gets a Hold from J.P. Morgan
November 7 at 3:03 PM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TEM/pressreleases/8717139/tempus-ai-inc-class-a-tem-gets-a-hold-from-jp-morgan/
A home office desk with a laptop displaying a Daily Market Pulse financial report, beside a coffee mug and notebook.
MarketBeat Week in Review – 11/2 - 11/6 (TEM)
...
November 7 at 7:00 AM  |  marketbeat.comhttps://www.marketbeat.com/articles/marketbeat-week-in-review-2026-11-2-11-6/
Tempus AI (NASDAQ:TEM) Stock Breaks Above Fifty Day Moving Average - Time to Sell?
November 7 at 6:00 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-tempus-ai-nasdaq-tem-stock-breaks-above-fifty-day-moving-average-time-to-sell-2026-11-07/
Tempus AI, Inc. $TEM Shares Newly Purchased by Mirae Asset Global Investments Co. Ltd.
November 6 at 5:11 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-tempus-ai-inc-tem-shares-newly-purchased-by-mirae-asset-global-investments-co-ltd-2026-11-06/
Tempus AI, Inc. (NASDAQ:TEM) Stock Has Average Price Target of $79.37 According to Brokerages
November 6 at 3:01 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31181361
Tempus AI, Inc. (NASDAQ:TEM) Stock Has Average Target Price of $79.37
November 6 at 2:28 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-tempus-ai-inc-nasdaq-tem-stock-has-average-target-price-of-7937-2026-11-06/
Promising Artificial Intelligence Stocks To Follow Today - November 5th
November 5 at 12:13 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-promising-artificial-intelligence-stocks-to-follow-today-november-5th-2026-11-05/
Tempus AI (NASDAQ:TEM) Director Sells $27,487.30 in Stock
November 5 at 6:52 AM  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-tem-insider-buying-and-selling-2026-11-05/
HC Wainwright Forecasts Strong Price Appreciation for Tempus AI (NASDAQ:TEM) Stock
November 5 at 2:55 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31179244
Robert W. Baird Forecasts Strong Price Appreciation for Tempus AI (NASDAQ:TEM) Stock
November 5 at 2:55 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31179246
Cantor Fitzgerald Forecasts Strong Price Appreciation for Tempus AI (NASDAQ:TEM) Stock
November 5 at 2:55 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31179238
Cantor Fitzgerald Keeps Their Buy Rating on Tempus AI, Inc. Class A (TEM)
November 5 at 2:36 AM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TEM/pressreleases/8644543/cantor-fitzgerald-keeps-their-buy-rating-on-tempus-ai-inc-class-a-tem/
Tempus AI (NASDAQ:TEM) Director David Epstein Sells 370 Shares of Stock
November 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-tempus-ai-nasdaq-tem-director-david-epstein-sells-370-shares-of-stock-2026-11-04/
AI stocks rise at the U.S. market open, with Tempus AI surging 5.21%.
November 4, 2026  |  kucoin.comK
Tempus AI, Inc. $TEM Stock Purchased by D.A. Davidson & CO.
November 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-tempus-ai-inc-tem-stock-purchased-by-da-davidson-co-2026-11-04/
Tempus AI (NASDAQ:TEM) Stock Price Expected to Rise, Needham & Company LLC Analyst Says
November 4, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31176916
Why did this Nancy Pelosi AI stock rally 10%?
November 3, 2026  |  finbold.comF
Artificial Intelligence Stocks To Consider - November 3rd
November 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-artificial-intelligence-stocks-to-consider-november-3rd-2026-11-03/
TEM Q3 Earnings Call Highlights Growth and 2027 Pricing Upside
November 3, 2026  |  zacks.comhttps://www.zacks.com/stock/news/3021839/tem-q3-earnings-call-highlights-growth-and-2027-pricing-upside?cid=cs-stocknewsapi-ft-analyst_blog_plus|earnings_call_takeaways-3021839
Tempus AI (TEM) Stock Looks Fully Priced Following Its 26% Run
November 3, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/tempus-ai-tem-stock-looks-110703334.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Grid of tiles depicting various industries, including a computer chip, excavator, rocket launch, and city skylines.
2026's ETF Boom Is Approaching 2,000 Launches: Watch These 3
By Nathan Reiff | October 19, 2026
Comfort Systems USA logo over rooftop HVAC units and piping at a data center facility during sunset.
Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
By Dan Schmidt | October 26, 2026
Johnson & Johnson logo displayed in a laboratory setting with vials, a microscope, and researchers in the background.
Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow Runway
By Thomas Hughes | October 13, 2026
Exterior of a Costco Wholesale store with its logo, parking lot, cars, and shopping carts visible.
Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
By Dan Schmidt | October 16, 2026
Garbage truck unloads at a recycling facility with baled cardboard and plastic near industrial processing towers.
3 Waste Services Stocks With More Growth Than You Might Expect
By Nathan Reiff | November 2, 2026
iShares Biotechnology ETF stock logo

iShares Biotechnology ETF NASDAQ:IBB

$213.63 +3.64 (+1.73%)
Closing price 11/6/2026 04:00 PM Eastern
Extended Trading
$213.96 +0.34 (+0.16%)
As of 11/6/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.

Recursion Pharmaceuticals stock logo

Recursion Pharmaceuticals NASDAQ:RXRX

$3.52 +0.02 (+0.57%)
Closing price 11/6/2026 04:00 PM Eastern
Extended Trading
$3.52 +0.00 (+0.14%)
As of 11/6/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Tempus AI stock logo

Tempus AI NASDAQ:TEM

$76.05 +5.62 (+7.98%)
Closing price 11/6/2026 04:00 PM Eastern
Extended Trading
$76.22 +0.17 (+0.23%)
As of 11/6/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas